0001493152-20-010464.txt : 20200603 0001493152-20-010464.hdr.sgml : 20200603 20200603154846 ACCESSION NUMBER: 0001493152-20-010464 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20200522 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200603 DATE AS OF CHANGE: 20200603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Qualigen Therapeutics, Inc. CENTRAL INDEX KEY: 0001460702 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 263474527 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37428 FILM NUMBER: 20939850 BUSINESS ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 BUSINESS PHONE: (760) 918-9165 MAIL ADDRESS: STREET 1: 2042 CORTE DEL NOGAL STREET 2: CARLSBAD CITY: CALIFORNIA STATE: CA ZIP: 92011 FORMER COMPANY: FORMER CONFORMED NAME: RITTER PHARMACEUTICALS INC DATE OF NAME CHANGE: 20090402 8-K/A 1 form8-ka.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K/A

(Amendment No. 1)

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 22, 2020

 

Qualigen Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-37428   26-3474527

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

2042 Corte Del Nogal, Carlsbad, California 92011

(Address of principal executive offices) (Zip Code)

 

(760) 918-9165

(Registrant’s telephone number, including area code)

 

n/a

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of each exchange on which registered
Common Stock, par value $.001 per share   QLGN   The Nasdaq Capital Market of The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (§230.405 of this chapter) or Rule 12b-2 of the Exchange Act (§240.12b-2 of this chapter).

 

Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act [  ]

 

 

 

 

 

 

Item 4.01. Change in Registrant’s Certifying Accountant.

 

As previously disclosed, on May 26, 2020, each of the Audit Committee of our board of directors and the full board of directors approved the dismissal of Mayer Hoffman McCann P.C. (“MHM”) as our independent registered public accounting firm and the engagement of Squar Milner LLP as the independent registered public accounting firm to audit Qualigen, Inc.’s financial statements for the fiscal year ended March 31, 2020. This Amendment No. 1 amends our Current Report on Form 8-K (which was filed on May 29, 2020) to provide the letter addressed to the Securities and Exchange Commission from MHM stating whether or not MHM agrees with the statements we had informed MHM we would be making in such Current Report in response to Item 4.01 and, if not, stating the respects in which MHM does not agree. A copy of MHM’s letter, dated June 2, 2020, is attached as Exhibit 16.1 hereto.

 

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

Item 8.01. Other Events.

 

In addition to the other disclosures under these items we made in the Current Report on Form 8-K we filed on May 29, 2020:

 

As previously disclosed in the joint proxy and consent solicitation statement/prospectus we filed with the Securities and Exchange Commission on April 6, 2020, effective on the date of our merger transaction with Qualigen, Inc. (May 22, 2020) our fiscal year was changed to a March 31 fiscal-year-end fiscal year in view of Qualigen, Inc.’s “accounting acquirer” status.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
     
16.1   Letter from Mayer Hoffman McCann P.C.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  QUALIGEN THERAPEUTICS, INC.
     
Date: June 3, 2020 By: /s/ Michael S. Poirier
    Michael S. Poirier, President and Chief Executive Officer

 

 

 

 

EX-16.1 2 ex16-1.htm

 

Exhibit 16.1

 

10474 Santa Monica Blvd., Suite 200 Los Angeles, CA 90025

Main: 310.268.2000 Fax: 310.268.2001 www.mhmcpa.com

 

June 2, 2020

 

U.S. Securities and Exchange Commission

450 Fifth Street NW

Washington, DC 20549

 

RE: Qualigen Therapeutics, Inc. Form 8-K (File No.: 001-37428)

 

We have read the statements made by Qualigen Therapeutics, Inc. in Item 4.01 of Form 8-K filed with the Securities and Exchange Commission on May 29, 2020 (copy attached). We agree with the statements concerning our Firm in such Form 8-K.

 

With respect to all other matters, we have no basis to either agree or disagree with the statements made therein.

 

 

Very truly yours,

 

 

Mayer Hoffman McCann P.C.

Los Angeles, CA

 

 

 

 

  

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 22, 2020

 

Qualigen Therapeutics, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-37428   26-3474527

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

2042 Corte Del Nogal, Carlsbad, California 92011

(Address of principal executive offices) (Zip Code)

 

(760) 918-9165

(Registrant’s telephone number, including area code)

 

 n/a

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading Symbol

  Name of each exchange on which registered
Common Stock, par value $.001 per share   QLGN   The Nasdaq Capital Market of The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act (§230.405 of this chapter) or Rule 12b-2 of the Exchange Act (§240.12b-2 of this chapter).

 

Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act [  ]

 

 

 

   

 

  

On May 22, 2020, Qualigen Therapeutics, Inc., formerly known as Ritter Pharmaceuticals, Inc. (the “Company”), completed its previously announced “reverse merger” transaction with Qualigen, Inc. (“Qualigen” – not to be confused with the Company) in accordance with the terms of the Agreement and Plan of Merger, dated as of January 15, 2020, by and among the Company, RPG28 Merger Sub, Inc. (“Merger Sub”), and Qualigen (as amended on February 1, 2020 and March 26, 2020, the “Merger Agreement”), pursuant to which Merger Sub merged with and into Qualigen with Qualigen surviving as a wholly owned subsidiary of the Company (the “Merger”). The former stockholders of Qualigen acquired, via the merger, a substantial majority of the shares of the Company.

 

Item 4.01. Change in Registrant’s Certifying Accountant.

 

For accounting purposes, the Merger is treated as a reverse acquisition and, as such, the historical financial statements of the accounting acquirer, Qualigen, which have been audited by Squar Milner LLP (“Squar”), became the historical financial statements of the Company. In a reverse acquisition, a change of accountants is presumed to have occurred unless the same accountant audited the pre-transaction financial statements of both the legal acquirer and the accounting acquirer, and such change is generally presumed to occur on the date the reverse acquisition is completed.

 

On May 26, 2020, each of the Audit Committee of the Company’s board of directors and the full board of directors approved the dismissal of Mayer Hoffman McCann P.C. (“MHM”) as the Company’s independent registered public accounting firm and the engagement of Squar as the independent registered public accounting firm to audit the Company’s financial statements for the fiscal year ended March 31, 2020, which will reflect Qualigen as the accounting acquirer.

 

The reports of MHM on the Company’s financial statements for each of the two fiscal years ended December 31, 2019 and December 31, 2018 did not contain an adverse opinion or a disclaimer of opinion, nor were they qualified or modified as to uncertainty, audit scope or accounting principles. The reports of MHM on the Company’s financial statements for each of the two fiscal years ended December 31, 2019 and December 31, 2018 contained an explanatory paragraph disclosing the uncertainty regarding the Company’s ability to continue as a going concern.

 

In connection with the audits of the Company’s financial statements for each of the two fiscal years ended December 31, 2019 and December 31, 2018 and the interim period between December 31, 2019 and the date of MHM’s dismissal, there were no “disagreements” (as that term is defined in Item 304(a)(1)(iv) of Regulation S-K and related instructions) between the Company and MHM on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure which, if not resolved to the satisfaction of MHM, would have caused MHM to make reference to the subject matter of the disagreement in its reports.

 

Within the fiscal years ended December 31, 2019 and December 31, 2018 and the interim period between December 31, 2019 and the date of MHM’s dismissal, there were no “reportable events” (as that term is defined in Item 304(a)(1)(v) of Regulation S-K and related instructions).

 

The Company has delivered to MHM a copy of the above disclosure and requested that MHM provide a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the statements made in response to this Item and, if not, stating the respects in which it does not agree.

 

2

 

  

Item 5.05. Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics.

 

In connection with the Merger, the Company’s board of directors adopted a code of business conduct and ethics (the “Code”) effective following the Merger. The Code superseded the Company’s existing code of business conduct and ethics previously adopted by its board of directors. The Code applies to all directors, officers and employees of the Company.

 

The existing code was refreshed and updated in connection with the Merger to conform the Code to reflect current best practices and enhance the Company personnel’s understanding of the Company’s standards of ethical business practices, promote awareness of ethical issues that may be encountered in carrying out an employee’s or director’s responsibilities, and improve its clarity as to how to address ethical issues that may arise.

 

The newly adopted Code did not result in any explicit or implicit waiver of any provision of the Company’s code of business conduct and ethics in effect before the adoption of the Code. The foregoing description of the Code does not purport to be complete and is qualified in its entirety by reference to the full text of the Code.

 

Item 5.08. Shareholder Director Nominations.

 

The Company’s board of directors has not yet set the date of the Company’s 2020 annual meeting of stockholders (the “Annual Meeting”) or the record date for stockholders entitled to notice of and to vote at the Annual Meeting. The anniversary of the date of the Company’s 2019 annual meeting of stockholders is June 14, 2020, and the Annual Meeting will not be held within 30 days after that anniversary. Qualified stockholder proposals or qualified stockholder nominations, including any notice on Schedule 14N, will be due to the Company no later than September 10, 2020, which is a reasonable time before the Company believes it would first mail its proxy materials for the Annual Meeting.

 

3

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  QUALIGEN THERAPEUTICS, INC.
     
Date: May 29, 2020 By: /s/ Michael S. Poirier
    Michael S. Poirier, President and Chief Executive Officer

 

4

 

GRAPHIC 3 ex16-1_001.jpg begin 644 ex16-1_001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# H'!PD'!@H)" D+"PH,#QD0#PX. M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_ MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T] M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P 1" !3 $ # 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#@***ZS5_! M L/!UIX@MKMYHY@C21-& 8PW0Y!YYP/QK2YY$8N5[=#DZ*ZCP?X+;Q3%>W$M MRUK;6H'SB/<7;&<#D=!_,563PY _@>7Q!]KD#IZDC?3R!Y0C!#YQCG/')J[=>"-G@6+Q';7;R!E#20- M&!L4MM)R#SS[=*+@J0@M9:9+ M)<[>C7$A4M]=HVK^=8VCW-O:?"&>2[L4O8AJ6/*>1D&<+SE>:YS1_%NH:+K% MWJ=N(9+JZ#"1IE+#YFW''([U&?$MT?#LNBB&V6TEF,YPIW!LYX.?;'TI6-?: MQM]YU>G7MG>_#;Q.;+3(K!5,098Y7DWG(Y^8\5>\/7B"#0-&O#BUU;2I8&!Z M!][%3^I'XBN)TK6=1@T2_P!(LK5)H+SFW^M7ITPG3FA. MF*J6YBA8$ $$9SG/(_G4MI:-CC)V32_JYVW@^%M#\2Z9X=)'GQ0375[M.096 M "C_ ("F/^^J\LG!6XE!ZAV!_.MNU\3ZII'B>ZUSLYK^Z2WMUW2.?P M ]3[5%%$\TJQQ*7=SA5'4FO0="T5-(M?FPUS(/WCCM_LCVKGQ&(5&/F=6%PS MKR\EN6-+TV'2K-8(>3U=^[GUJMK^MKI%MB,AKJ0?NU_NC^\:L:MJD6DV9FE^ M9SQ&G=C_ (5YW=W4M[EBL2J$/9T]_P B M.21Y9&DD8L['+,3R33:**]@\,*.M%7]'O;73[O[1PW#.SQ M2)M&>BD=1^/6NGR] MCR\?2Y*O-T84445V'"%%%% !71^#M0\B]>S<_)/RGLX_Q'\JYRG12O#*DL9V MNC!E/H16=6FJD'%FM&JZ5131ZK7!>*M.^Q:J94&(KCYQ[-_$/Z_C7:V%XE_8 MPW,?21A[C\ZI^(M._M'29%49EB_>1_AU'XBO'PU1TJMGZ,]S%TE6HWCZH M\\HHHKW#YX**** "BBB@#LO!,C-87*%B524;1Z9'-=+117@XK^-(^CP?\")Y =GJL:Q:M=I&H5%F8 #MS52BBO GRAPHIC 4 ex16-1_002.jpg begin 644 ex16-1_002.jpg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end GRAPHIC 5 ex16-1_004.jpg begin 644 ex16-1_004.jpg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end